BACKGROUND: Leishmaniasis is a disease caused by protozoan parasites of genus Leishmania. The frequent involvement of Leishmania tropica in human leishmaniasis has been recognized only recently. Similarly as L. major, L. tropica causes cutaneous leishmaniasis in humans, but can also visceralize and cause systemic illness. The relationship between the host genotype and disease manifestations is poorly understood because there were no suitable animal models. METHODS: We studied susceptibility to L. tropica, using BALB/c-c-STS/A (CcS/Dem) recombinant congenic (RC) strains, which differ greatly in susceptibility to L. major. Mice were infected with L. tropica and skin lesions, cytokine and chemokine levels in serum, and parasite numbers in organs were measured. PRINCIPAL FINDINGS: Females of BALB/c and several RC strains developed skin lesions. In some strains parasites visceralized and were detected in spleen and liver. Importantly, the strain distribution pattern of symptoms caused by L. tropica was different from that observed after L. major infection. Moreover, sex differently influenced infection with L. tropica and L. major. L. major-infected males exhibited either higher or similar skin pathology as females, whereas L. tropica-infected females were more susceptible than males. The majority of L. tropica-infected strains exhibited increased levels of chemokines CCL2, CCL3 and CCL5. CcS-16 females, which developed the largest lesions, exhibited a unique systemic chemokine reaction, characterized by additional transient early peaks of CCL3 and CCL5, which were not present in CcS-16 males nor in any other strain. CONCLUSION: Comparison of L. tropica and L. major infections indicates that the strain patterns of response are species-specific, with different sex effects and largely different host susceptibility genes.

Laboratory of Molecular and Cellular Immunology Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Rittig MG, Bogdan C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today. 2000;16:292–297. PubMed

Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13:151–177. PubMed

McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev. 2004;201:206–224. PubMed

Farrell JP. Leishmania. Boston, Dordrecht, London: Kluwer Academic Publishers; 2002. 193

Kobets T, Grekov I, Lipoldová M. Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem. 2012;19:1443–1474. PubMed

Herwaldt BL. Leishmaniasis. Lancet. 1999;354:1191–1199. PubMed

Lipoldová M, Demant P. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet. 2006;7:294–305. PubMed

Jacobson RL. Leishmania tropica (Kinetoplastida: Trypanosomatidae) - a perplexing parasite. Folia Parasit. 2003;50:241–250. PubMed

Svobodova M, Votypka J, Peckova J, Dvorak V, Nasereddin A, et al. Distinct transmission cycles of Leishmania tropica in 2 adjacent foci, Northern Israel. Emerg Infect Dis. 2006;12:1860–1868. PubMed PMC

Magill AJ, Grögl M, Gasser RA, Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med. 1993;328:1383–1387. PubMed

Sacks DL, Kenney RT, Kreutzer RD, Jaffe CL, Gupta AK, et al. Indian kala-azar caused by Leishmania tropica. Lancet. 1995;345:959–961. PubMed

Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, et al. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am J Trop Med Hyg. 2008;79:435–437. PubMed

Lira R, Méndez S, Carrera L, Jaffe C, Neva F, et al. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol. 1998;89:331–342. PubMed

Girginkardeşler N, Balcioğlu IC, Yereli K, Özbilgin A, Özbel Y, et al. Cutaneous leishmaniasis infection in BALB/c mice using a Leishmania tropica strain isolated from Turkey. J Parasitol. 2001;87:1177–1178. PubMed

Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2:845–858. PubMed

Anderson CF, Lira R, Kamhawi S, Belkaid Y, Wynn TA, et al. IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol. 2008;180:4090–4097. PubMed

Demant P, Hart AAM. Recombinant congenic strains – a new tool for analysing genetic traits determined by more than one gene. Immunogenetics. 1986;24:416–422. PubMed

Demant P, Lipoldová M, Svobodová M. Resistance to Leishmania major in mice. Science. 1996;274:1392–1393. PubMed

Lipoldová M, Svobodová M, Krulová M, Havelková H, Badalová J, et al. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 2000;1:200–206. PubMed

Vladimirov V, Badalová J, Svobodová M, Havelková H, Hart AAM, et al. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect Immun. 2003;71:2041–2046. PubMed PMC

Havelková H, Badalová J, Svobodová M, Vojtíšková J, Kurey I, et al. Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun. 2006;7:220–233. PubMed

Kurey I, Kobets T, Havelková H, Slapničková M, Quan L, et al. Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics. 2009;61:619–633. PubMed PMC

Stassen AP, Groot PC, Eppig JT, Demant P. Genetic composition of the recombinant congenic strains. Mamm Genome. 1996;7:55–58. PubMed

Grekov I, Svobodová M, Nohýnková E, Lipoldová M. Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium. J Microbiol Methods. 2011;87:273–277. PubMed

Rogers ME, Ilg T, Nikolaev AV, Ferguson MAJ, Bates PA. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature. 2004;430:463–467. PubMed PMC

Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 1985;7:545–555. PubMed

Kobets T, Badalová J, Grekov I, Havelková H, Svobodová M, et al. Leishmania parasite detection and quantification using PCR-ELISA. Nat Protoc. 2010;5:1074–1080. PubMed

Lipoldová M, Svobodová M, Havelková H, Krulová M, Badalová J, et al. Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics. 2002;54:174–183. PubMed

Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 1980;2:303–314. PubMed

Longley R, Smith C, Fortin A, Berghout J, McMorran B, et al. Host resistance to malaria: using mouse models to explore the host response. Mamm Genome. 2011;22:32–42. PubMed

Lipoldová M, Kosařová M, Zajícová A, Holáň V, Hart AA, et al. Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics. 1995;41:301–311. PubMed

Holáň V, Lipoldová M, Demant P. Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2. Immunogenetics. 1996;44:27–35. PubMed

Havelková H, Badalová J, Demant P, Lipoldová M. A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA. Genes Immun. 2000;1:483–487. PubMed

Lipoldová M, Havelková H, Badalová J, Demant P. Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function and lung tumor susceptibility. Int J Cancer. 2005;114:394–399. PubMed

Havelková H, Holáň V, Kárník I, Lipoldová M. Mouse model for analysis of non-MHC genes that influence allogeneic response: recombinant congenic strains of OcB/Dem series that carry identical H2 locus. Cent Eur J Biol. 2006;1:16–28.

Šíma M, Havelková H, Quan L, Svobodová M, Jarošíková T, et al. Genetic control of resistance to Trypanosoma brucei brucei infection in mice. PLoS Negl Trop Dis. 2011;5:e1173. PubMed PMC

Shockley KR, Churchill GA. Gene expression analysis of mouse chromosome substitution strains. Mamm Genome. 2006;17:598–614. PubMed

Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, et al. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet. 2003;35:357–362. PubMed

Alexander J. Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology. 1988;96(Pt 2):297–302. PubMed

Mock BA, Nacy CA. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun. 1988;56:3316–3319. PubMed PMC

Giannini MS. Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice. Parasite Immunol. 1986;8:31–37. PubMed

Alexander J, Irving K, Snider H, Satoskar A. Klein SL, Roberts CW, editors. Sex hormones of host responses against parasites. Sex hormons and immunity to infection. 2010. pp. 147–186. Springer Heildelberg, Dordrecht, London, New York, 2010.

Sakthianandeswaren A, Curtis JM, Elso C, Kumar B, Baldwin TM, et al. Fine mapping of Leishmania major susceptibility locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun. 2010;78:2734–2744. PubMed PMC

Lee AH, Hong JH, Seo YS. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J. 2000;350 Pt 1:131–138. PubMed PMC

Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25:787–820. PubMed

Teixeira JM, Teixeira CR, Andrade BB, Barral-Netto M, Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 2006;22:32–40. PubMed

Oghumu S, Lezama-Davila CM, Isaac-Marquez AP, Satoskar AR. Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol. 2010;126:389–396. PubMed PMC

Battacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, et al. Chemokine-induced leishmanicidal activity in murine macrophages via generation of nitric oxide. J Infect Dis. 2002;185:1704–1708. PubMed

Brandonisio O, Panaro MA, Fumarola L, Sisto M, Leogrande D, et al. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1α induce nitric oxide release and enchance parasite killing in Leishmania infantum-infected macrophages. Clin Exp Med. 2002;2:125–129. PubMed

Da Costa Santiago H, Ferreira Oliveira C, Santiago L, Oliveira Ferraz F, de Glória de Souza D, et al. Involvement of chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun. 2004;72:4918–4923. PubMed PMC

Ritter U, Moll H, Laskay T, Brocker E, Velazco O, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis. 1996;173:699–709. PubMed

Johnson J, Suzuki Y, Mack D, Mui E, Estes R, et al. Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol. 2002;32:179–185. PubMed

Masocha W, Amin DN, Kristensson K, Rottenberg ME. Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice. Scand J Immunol. 2008;68:484–491. PubMed

Rathkolb B, Noyes HA, Brass A, Dark P, Fuchs H, et al. Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection. Infect Immun. 2009;77:3948–3957. PubMed PMC

Helegbe GK, Yanagi T, Senba M, Huy NT, Shuaibu MN, et al. Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure. Parasitol Res. 2011;108:807–814. PubMed

Genotype-driven sensitivity of mice to tick-borne encephalitis virus correlates with differential host responses in peripheral macrophages and brain

Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions

Gene-Specific Sex Effects on Susceptibility to Infectious Diseases

Genetic Influence on Frequencies of Myeloid-Derived Cell Subpopulations in Mouse

Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice

Novel Loci Controlling Parasite Load in Organs of Mice Infected With Leishmania major, Their Interactions and Sex Influence

Genetic Regulation of Guanylate-Binding Proteins 2b and 5 during Leishmaniasis in Mice

Gene-specific sex effects on eosinophil infiltration in leishmaniasis

Mapping the genes for susceptibility and response to Leishmania tropica in mouse

Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system